UPDATE 1-Agenus brain cancer vaccine doubles survival rate in study

July 1, 2014 12:20 PM

10 0

July 1 (Reuters) - Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.

The biotechnology company's shares jumped 23 percent to $3.96 before the bell.

Also read: Low vitamin D levels linked to relapse of ulcerative colitis

Read more

To category page